In focus
Latest feed
FDA Greenlights Zenbexus: A New Era for Multiple Myeloma Treatment
A New Dawn for Multiple Myeloma Patients: FDA Approves Bristol-Myers Squibb's Zenbexus
Navigating the Dragon's Gate: India's Persistent Push for Fairer Trade Access in China
The No Surprises Act's Unintended Consequence: A Multi-Billion Dollar Headache for Healthcare
